Clasificación en acciones
#33662
TME Pharma N.V., a biopharmaceutical company in the clinical development stage... TME Pharma N.V., a biopharmaceutical company in the clinical development stage based in Berlin, Germany, is dedicated to pioneering innovative therapeutic solutions for cancer. The company leverages its unique Spiegelmer platform to advance a pipeline of investigational drug candidates. Its primary oncology asset, NOX-A12, is currently being evaluated in clinical studies as a combination therapy for a range of challenging cancers, including metastatic pancreatic and colorectal cancer, glioblastoma, and myeloma. Beyond its cancer-focused efforts, TME Pharma also developed NOX-E36, which has successfully concluded Phase 1/2 clinical trials for diabetic nephropathy. The company has formed a strategic collaboration with Merck Sharp & Dohme Corp. to explore NOX-A12 in combination with Keytruda and two different chemotherapy protocols as a second-line intervention for patients battling metastatic pancreatic cancer. Founded in 1997, the organization adopted its current name, TME Pharma N.V., in July 2022, having previously operated as NOXXON Pharma N.V.
Precio por acción
$0.07591393
Última sincronización: 2026-08-14
Capitalización bursátil
$7.15M
Comercio TME Pharma N.V. (ALTME)
Precio ALTME con Capital del mercado a B
Capitalización de mercado de TME Pharma N.V.(ALTME)
Capitalización bursátil: $7.15M
A fecha de August 2026, TME Pharma N.V. tiene una capitalización de mercado de $7.15M. Esto convierte a TME Pharma N.V. en la 33662nd empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de TME Pharma N.V. desde 2016 hasta 2026
ALTME en comparación con los más populares 5 títulos stocks
| Precio por ALTME |
|
Activo B |
Capital del mercado en B |
Resultados |
|
|
|
|
$5.452T
|
+76,244,200.20%
|
|
|
|
|
$4.490T
|
+62,792,774.37%
|
|
|
|
|
$4.162T
|
+58,211,108.67%
|
|
|
|
|
$3.676T
|
+51,413,501.77%
|
|
|
|
|
$2.833T
|
+39,619,964.72%
|
